Burning Rock Biotech (BNR) Gross Profit (2019 - 2025)

Burning Rock Biotech's Gross Profit history runs 7 years deep, the most recent figure standing at $14.1 million for Q4 2025.

• In Q4 2025, Gross Profit rose 15.05% year-over-year to $14.1 million; the TTM figure through Dec 2025 stood at $56.5 million (up 12.22% YoY), while the FY2025 annual figure was $57.6 million, up 16.05% from the prior year.
• Gross Profit was $14.1 million for Q4 2025 at Burning Rock Biotech, up from $13.9 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $16.5 million in Q4 2021 to a low of $11.0 million in Q4 2023.
• Historically, Gross Profit has averaged $13.5 million across 5 years, with a median of $13.8 million in 2022.
• The sharpest annual moves came in 2021 and 2023: Gross Profit jumped 83.01% in 2021, then declined 25.06% in 2023.
• A 5-year view of Gross Profit shows it stood at $16.5 million in 2021, then decreased by 11.22% to $14.7 million in 2022, then slipped by 25.06% to $11.0 million in 2023, then climbed by 11.35% to $12.3 million in 2024, then grew by 15.05% to $14.1 million in 2025.
• The last three Gross Profit figures came in at $14.1 million (Q4 2025), $13.9 million (Q3 2025), and $15.1 million (Q2 2025), per Business Quant data.